# Karin Hehenberger

> Karin Hehenberger is a Series A investor at LyfeBulb (New York) backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [LyfeBulb](https://shizune.co/investors/profile/lyfebulb)
- Location: New York, United States
- Total investments: 1
- Last investment: Sep 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/karin-hehenberger-67526b10/

Karin Hehenberger is a Series A investor at LyfeBulb in New York focused on Medical and Biopharma. Karin Hehenberger is the Founder & Chief Executive Officer at Lyfebulb. She has also attended Harvard Medical School in 1998.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AnaCardio | AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure. | $14M | Series A | Sep 07, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Flerie Invest](https://shizune.co/investors/profile/flerie-invest) — VC Fund, 1 deal together
- [Industrifonden](https://shizune.co/investors/profile/industrifonden) — VC Fund, 1 deal together

## About LyfeBulb

VC Fund



5 contacts available at LyfeBulb.

| Name | Title | Profile |
| --- | --- | --- |
| Karin Hehenberger | Founder & CEO | https://shizune.co/investors/profile/karin-hehenberger |
| Stephen Squinto | Chairman | https://shizune.co/investors/profile/stephen-squinto |
| Anthony Y. Sun | Advisory Board | https://shizune.co/investors/profile/anthony-y-sun |
| Lisa Hehenberger | Advisory Board | https://shizune.co/investors/profile/lisa-hehenberger |
| Riccardo Braglia | Executive Board | https://shizune.co/investors/profile/riccardo-braglia |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Karin Hehenberger invest in?

Karin Hehenberger invests primarily in Medical and Biopharma startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Karin Hehenberger last invest?

The most recent investment recorded for Karin Hehenberger closed in Sep 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co